Logo

Latest Press Releases

November 5, 2025
Neurona Therapeutics Announces Priority Medicines (PRIME) Designation Granted by the European Medicines Agency (EMA) to NRTX-1001 in the Treatment of Drug-Resistant Focal Epilepsy

October 7, 2025
Neurona Expands Investigation of NRTX-1001 Cell Therapy into Mesial Temporal Lobe Epilepsy (MTLE) without Mesial Temporal Sclerosis (MTS)

July 11, 2025
Neurona Announces Publication in Neuron Reporting Durable Preclinical Engraftment of Human Interneuron Cell Therapy 

More Press Releases

photo of neuron

In the news

Click to play video of Interview with patient caregiver

Interview with patient caregiver at the XVII Conference on Epilepsy Therapies & Diagnostics Development (ETDD)
(with permission from ETDD, patient and caregiver)

August 25, 2025
Regenerative medicine offers new hope for lasting seizure relief for drug-resistant epilepsy

June 19, 2025
UChicago Medicine doctors provide pioneering stem cell surgery to patient with drug-resistant epilepsy

June 17, 2025
UAMS performs state's first cell therapy epilepsy Surgery

More News Articles

Events

There are no upcoming events at this time.

More Events

  • About
    • Mission / Vision
    • Leadership
    • Board of Directors
    • Scientific Advisors
    • Investors
  • Technology
    • Approach
    • Manufacturing
    • Publications
    • Scientific Presentations
  • Pipeline
    • Programs
  • Clinical Trials
    • NTE001 Unilateral MTLE Trial
    • CT.gov: NTE001
    • NTE002 Bilateral MTLE Trial
    • CT.gov: NTE002
    • Expanded Access Program
  • News
    • Press Releases
    • In the News
    • Events
  • Careers
    • Culture
    • Values
    • Benefits
    • Visiting Scientists & Internship programs
    • Job Opportunities
  • Contact
  • Home
  • About
    • Mission / Vision
    • Leadership
    • Board of Directors
    • Scientific Advisors
    • Investors
  • Technology
    • Approach
    • Manufacturing
    • Publications
    • Scientific Presentations
  • Pipeline
    • Programs
  • Clinical Trials
    • NTE001 Unilateral MTLE Trial
    • CT.gov: NTE001
    • NTE002 Bilateral MTLE Trial
    • CT.gov: NTE002
    • Expanded Access Program
  • News
    • Press Releases
    • In the News
    • Events
  • Careers
    • Culture
    • Values
    • Benefits
    • Visiting Scientists & Internship programs
    • Job Opportunities
  • Contact
Logo
Neurona Therapeutics
170 Harbor Way
South San Francisco, CA 94080
info@neuronatx.com
LinkedIn
© 2025 Neurona Therapeutics All rights reserved
  • Terms of Use
  • Privacy Policy
Website Design : Hane Chow, Inc.